APOA2 抗体 (HRP)
Quick Overview for APOA2 抗体 (HRP) (ABIN7449328)
抗原
See all APOA2 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
原理
- Goat anti-Human Apo AII [H04] Antibody HRP Conjugated
-
免疫原
- Human Apolipoprotein AII
-
亚型
- IgG
-
-
anti-Apolipoprotein A-II (APOA2) (AA 1-100) antibody
APOA2 适用: 人 WB, ELISA, IHC (p), IF 宿主: 小鼠 Monoclonal 1H6 unconjugated
anti-Apolipoprotein A-II (APOA2) (AA 24-100) antibodyAPOA2 适用: 人, 大鼠 ELISA, IHC (p), IF (cc), IF (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein A-II (APOA2) (AA 24-100) antibodyAPOA2 适用: 人 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein A-II (APOA2) antibodyAPOA2 适用: 人 WB, IHC, ELISA, FACS 宿主: 兔 Monoclonal 6H2 unconjugated Recombinant Antibody
anti-Apolipoprotein A-II (APOA2) (AA 28-56) antibodyAPOA2 适用: 人 WB, IHC (p) 宿主: 兔 Polyclonal RB15149 unconjugated
anti-Apolipoprotein A-II (APOA2) (AA 1-100) antibodyAPOA2 适用: 人 WB, IF 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein A-II (APOA2) (AA 24-102) antibodyAPOA2 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein A-II (APOA2) (AA 1-101) antibodyAPOA2 适用: 人 WB, IHC (p), EIA 宿主: 小鼠 Monoclonal 1H6 unconjugated
anti-Apolipoprotein A-II (APOA2) (AA 1-100) antibodyAPOA2 适用: 人 WB, ELISA 宿主: 小鼠 Polyclonal unconjugated
anti-Apolipoprotein A-II (APOA2) antibodyAPOA2 适用: 大鼠, 小鼠 IHC, IF 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
WB: 1:1,000 - 1:8,000
ELISA: 1:1,000 - 1:8,000
-
限制
- 仅限研究用
-
-
-
浓度
- 1 mg/mL
-
缓冲液
- 50 mM PBS, 0.1 M NaCl, and 0.01 % Thiomersal, pH 7.4
-
储存液
- Thimerosal (Merthiolate)
-
注意事项
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
有效期
- 12 months
-
-
- APOA2 (Apolipoprotein A-II (APOA2))
-
别名
- ApoAII
-
背景
- Background: Apo AII comprises 25 % of HDL. It exists in human plasma as a dimer of 2 identical chains of 77 amino acid residues, joined by disulfide. The molecular weight is reported to be 8.7 kDa for a single chain (Brewer et al., 1972).Studies on mouse reported that apo AII may be proatherogenic (Warden et al., 1993), however, case-control study in the large European Prospective Investigation demonstrated that plasma Apo AII concentrations were strongly inversely correlated with CHD events. (Birjmohun et al., 2007)
-
基因ID
- 336
-
NCBI登录号
- NP_001634
-
UniProt
- P02652
-
途径
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism
抗原
-
